Mutual of America Capital Management LLC Increases Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Mutual of America Capital Management LLC boosted its position in OrthoPediatrics Corp. (NASDAQ:KIDS) by 195.1% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 107,609 shares of the company’s stock after acquiring an additional 71,146 shares during the period. Mutual of America Capital Management LLC’s holdings in OrthoPediatrics were worth $2,917,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of KIDS. International Assets Investment Management LLC lifted its holdings in shares of OrthoPediatrics by 2,610.8% during the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock worth $27,000 after acquiring an additional 966 shares during the period. Quest Partners LLC acquired a new position in OrthoPediatrics during the second quarter worth approximately $34,000. SG Americas Securities LLC purchased a new position in OrthoPediatrics during the second quarter worth approximately $110,000. State Board of Administration of Florida Retirement System acquired a new position in shares of OrthoPediatrics in the 1st quarter valued at $178,000. Finally, Deerfield Management Company L.P. Series C purchased a new stake in shares of OrthoPediatrics during the 2nd quarter valued at $203,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

OrthoPediatrics Stock Performance

NASDAQ:KIDS opened at $26.34 on Friday. OrthoPediatrics Corp. has a twelve month low of $22.41 and a twelve month high of $36.23. The firm has a market capitalization of $637.95 million, a price-to-earnings ratio of -21.41 and a beta of 1.16. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. The firm’s fifty day simple moving average is $26.45 and its 200 day simple moving average is $29.35.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Needham & Company LLC reiterated a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Friday, November 8th. Truist Financial cut their price objective on OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a report on Monday, October 14th. Finally, JMP Securities reiterated a “market outperform” rating and set a $50.00 target price on shares of OrthoPediatrics in a report on Friday, September 13th.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.